The GeneSight test helps healthcare providers make better treatment decisions based on a person’s genetic makeup. GeneSight testing is based on advanced CPGx® technology, a patented approach that analyzes variations and combinations of a person’s genes along with FDA-approved medications for behavioral health conditions and chronic pain. Numerous peer-reviewed, published studies have proven its clinical benefits and substantial healthcare cost savings. More than 18,000 healthcare professionals have used GeneSight to improve healthcare for more than 500,000 patients. Learn more at www.GeneSight.com.
Depression is a common and serious mood disorder that affects nearly 1 in 5 adults, or 19 million people, in the United States. For these patients, the appropriate treatment may be life-saving. Yet half of patients with depression will fail to respond to their first prescribed medication, leading patients on a medication odyssey of trial-and-error treatments that can last for years.
Posted
and last updated
Copyright 2017 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
